| NIDC: National Isotope Development Center

Isotope Product Catalog

With 225+ isotopes available for purchase, the U.S. Department of Energy Isotope Program is the world leader in quality, purity, and availability of the most sought after and rare isotopes.

NIDC Product Catalog

Barium-133 Available Now!

The DOE IP is pleased to announce a new batch of Barium-133 is available for purchase now.

More Information

Barium-133 is available now

New FOA: Advancing Novel Medical Isotopes for Clinical Trials

The DOE Office of Science is excited to announce a new Funding Opportunity for Traineeship in Isotope R&D and Production.

FOA: Advancing Novel Medical Isotopes for Clinical Trials

DOE IP Response to COVID-19

An update on what the DOE IP is currently doing to mitigate the spread of COVID-19.

More Information

DOE IP & NIDC Response to COVID-19

Translating Research to Applications

Get a behind-the-scenes look at the production of isotopes across the Department's facilities that are critical to everyday applications, particularly in the medical arena.

DOE IP Video Still - 2019 SNMMI

Medical Isotopes

With more than 35 medically relevant isotopes available and others under investigation, the NIDC is committed to supplying the world with the highest quality isotopes for medical use.

Download Brochure

Image of brain scans

Technical Resources

Need a custom service for your order? We offer a wide variety of special services to complement our radioactive and stable isotope offerings.

Technical Resources

Technical Resources

Our mission is to support the U.S. Department of Energy Isotope Program as the global leader in the production and distribution of radioactive and enriched stable isotopes that are deemed critical or are in short supply.

NIDC News

Join us at SNMMI~

Join Us At SNMMI!

Visit the DOE IP booth at the virtual SNMMI Annual Meeting

Barium-133 is available now

A New Batch of Barium-133 is Available Now!

A limited quantity of barium-133 is now available through the DOE IP in millicurie quantities.

Funding Opportunity Announcement for Advancing Novel Medical Isotopes for Clinical Trials

Funding Opportunity Announcement: Advancing Novel Medical Isotopes for Clinical Trials

The DOE Isotope Program is excited to announce a new Funding Opportunity

DOE Isotope Program Highlights

Image courtesy of Jon Burns, Texas A&M University At-211 – ketone interaction within the chromatography column.

New Elegant Method for Rapid Recovery of Anti-Cancer Agent At-211

April 30, 2021

A high-speed, high-yield recovery approach for At-211 means improved availability of this cancer-treating isotope.

Image courtesy of Donald Montoya, Los Alamos National Laboratory Cerium-134 can be targeted to provide an imaging analogue for two different therapy isotopes, actinium-225 and thorium-227. This helps scientists understand these therapy isotopes and develop new treatments. These novel isotopes are being developed and produced by the DOE Isotope Program.

New Imaging Isotope Meets Promising Therapy Isotopes

April 30, 2021

New production methods for Ce-134 advance technologies for imaging human disease and guiding treatment.

Julie Ezold has been elected to a three-year term on the American Nuclear Society’s Board of Directors.

Ezold elected to the ANS Board of Directors

April 26, 2021

Julie Ezold, section head at ORNL, has been elected to a three-year term on the American Nuclear Society’s Board of Directors.

Increasing the Arsenal of Radioisotopes in the Fight Against Cancer

Increasing the Arsenal of Radioisotopes in the Fight Against Cancer

April 1, 2021

A new supply of a critical radioisotope advances personalized medicine.